BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 11315914)

  • 1. High-dose chemotherapy and autologous hematopoietic stem cell transplantation in patients with rheumatoid arthritis: results of an open study to assess feasibility, safety, and efficacy.
    Verburg RJ; Kruize AA; van den Hoogen FH; Fibbe WE; Petersen EJ; Preijers F; Sont JK; Barge RM; Bijlsma JW; van de Putte LB; Breedveld FC; van Laar JM
    Arthritis Rheum; 2001 Apr; 44(4):754-60. PubMed ID: 11315914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intensified-dose (4 gm/m2) cyclophosphamide and granulocyte colony-stimulating factor administration for hematopoietic stem cell mobilization in refractory rheumatoid arthritis.
    Breban M; Dougados M; Picard F; Zompi S; Marolleau JP; Bocaccio C; Heshmati F; Mezieres M; Dreyfus F; Bouscary D
    Arthritis Rheum; 1999 Nov; 42(11):2275-80. PubMed ID: 10555020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pilot randomized trial comparing CD34-selected versus unmanipulated hemopoietic stem cell transplantation for severe, refractory rheumatoid arthritis.
    Moore J; Brooks P; Milliken S; Biggs J; Ma D; Handel M; Cannell P; Will R; Rule S; Joske D; Langlands B; Taylor K; O'Callaghan J; Szer J; Wicks I; McColl G; Passeullo F; Snowden J
    Arthritis Rheum; 2002 Sep; 46(9):2301-9. PubMed ID: 12355477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autologous hemopoietic stem cell transplantation in severe rheumatoid arthritis: a report from the EBMT and ABMTR.
    Snowden JA; Passweg J; Moore JJ; Milliken S; Cannell P; Van Laar J; Verburg R; Szer J; Taylor K; Joske D; Rule S; Bingham SJ; Emery P; Burt RK; Lowenthal RM; Durez P; McKendry RJ; Pavletic SZ; Espigado I; Jantunen E; Kashyap A; Rabusin M; Brooks P; Bredeson C; Tyndall A
    J Rheumatol; 2004 Mar; 31(3):482-8. PubMed ID: 14994391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomised, blinded, placebo-controlled, dose escalation study of the tolerability and efficacy of filgrastim for haemopoietic stem cell mobilisation in patients with severe active rheumatoid arthritis.
    Snowden JA; Biggs JC; Milliken ST; Fuller A; Staniforth D; Passuello F; Renwick J; Brooks PM
    Bone Marrow Transplant; 1998 Dec; 22(11):1035-41. PubMed ID: 9877264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intensive immunosuppression and autologous stem cell transplantation for patients with severe rheumatoid arthritis: the Leiden experience.
    van Laar JM; Verburg RJ; Fibbe WE; Breedveld FC
    J Rheumatol Suppl; 2001 Oct; 64():25-7. PubMed ID: 11642499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase I/II dose escalation study of intensified cyclophosphamide and autologous blood stem cell rescue in severe, active rheumatoid arthritis.
    Snowden JA; Biggs JC; Milliken ST; Fuller A; Brooks PM
    Arthritis Rheum; 1999 Nov; 42(11):2286-92. PubMed ID: 10555022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High dose chemotherapy and hematopoietic stem cell transplantation: a study of treatment preference in patients with rheumatoid arthritis and rheumatologists.
    Verburg RJ; Mahabali SD; Stiggelbout AM; Sont JK; van Laar JM
    J Rheumatol; 2002 Aug; 29(8):1653-8. PubMed ID: 12180724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term followup of health status in patients with severe rheumatoid arthritis after high-dose chemotherapy followed by autologous hematopoietic stem cell transplantation.
    Teng YK; Verburg RJ; Sont JK; van den Hout WB; Breedveld FC; van Laar JM
    Arthritis Rheum; 2005 Aug; 52(8):2272-6. PubMed ID: 16052541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytoreduction of lymphoid malignancies and mobilization of blood hematopoietic progenitor cells with high doses of cyclophosphamide and etoposide plus filgrastim.
    Damon L; Rugo H; Tolaney S; Navarro W; Martin T; Ries C; Case D; Ault K; Linker C
    Biol Blood Marrow Transplant; 2006 Mar; 12(3):316-24. PubMed ID: 16503501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autologous stem cell transplantation for rheumatoid arthritis--interim report of 6 patients.
    Bingham SJ; Snowden J; McGonagle D; Richards S; Isaacs J; Morgan G; Emery P
    J Rheumatol Suppl; 2001 Oct; 64():21-4. PubMed ID: 11642498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
    Arora M; Burns LJ; Barker JN; Miller JS; Defor TE; Olujohungbe AB; Weisdorf DJ
    Biol Blood Marrow Transplant; 2004 Jun; 10(6):395-404. PubMed ID: 15148493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High dose chemotherapy followed by autologous peripheral blood stem cell transplantation or conventional pharmacological treatment for refractory rheumatoid arthritis? A Markov decision analysis.
    Verburg RJ; Sont JK; Vliet Vlieland TP; Landewé RB; Boers M; Kievit J; van Laar JM
    J Rheumatol; 2001 Apr; 28(4):719-27. PubMed ID: 11327241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hematopoietic stem cell transplantation for severe and refractory lupus. Analysis after five years and fifteen patients.
    Traynor AE; Barr WG; Rosa RM; Rodriguez J; Oyama Y; Baker S; Brush M; Burt RK
    Arthritis Rheum; 2002 Nov; 46(11):2917-23. PubMed ID: 12428232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensive immunoablation and autologous blood stem cell transplantation in patients with refractory rheumatoid arthritis: the University of Nebraska experience.
    Pavletic SZ; Odell JR; Pirruccello SJ; Ursick MM; Haire CE; Sharp JG; Kessinger A; Klassen LW
    J Rheumatol Suppl; 2001 Oct; 64():13-20. PubMed ID: 11642497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of severe systemic autoimmune diseases with autologous peripheral blood stem cell transplantation].
    Zhao Y; Zhou DB; Leng XM; Wang SJ; Li TS; Duan Y; Shen T; Zhao YQ; Zhang JP; Bai LJ; Cui W; Zhang FQ; Zeng XF; Zhang FC; Dong Y; Tang FL
    Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(24):2077-81. PubMed ID: 15730620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autologous haematopoietic stem cell transplantation without CD34+ cell selection in refractory Crohn's disease.
    Cassinotti A; Annaloro C; Ardizzone S; Onida F; Della Volpe A; Clerici M; Usardi P; Greco S; Maconi G; Porro GB; Deliliers GL
    Gut; 2008 Feb; 57(2):211-7. PubMed ID: 17895357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autologous hematopoietic stem cell transplantation in refractory rheumatoid arthritis: sustained response in two of four patients.
    Burt RK; Georganas C; Schroeder J; Traynor A; Stefka J; Schuening F; Graziano F; Mineishi S; Brush M; Fishman M; Welles C; Rosen S; Pope R
    Arthritis Rheum; 1999 Nov; 42(11):2281-5. PubMed ID: 10555021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DCEP chemotherapy followed by a single, fixed dose of pegylated filgrastim allows adequate stem cell mobilization in multiple myeloma patients.
    Zappasodi P; Nosari AM; Astori C; Ciapanna D; Bonfichi M; Varettoni M; Mangiacavalli S; Morra E; Lazzarino M; Corso A
    Transfusion; 2008 May; 48(5):857-60. PubMed ID: 18248573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Autologous peripheral blood stem cells mobilization with etoposide plus rhG-CSF versus cyclophosphamide plus rhG-CSF].
    Shi YK; He XH; Han XH; Liu P; Yang JL; Zhou SY; Zhou AP; Zhang CG; Ai B
    Ai Zheng; 2003 Dec; 22(12):1311-6. PubMed ID: 14693058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.